An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
about
New approaches to vaccine adjuvants: inhibiting the inhibitorBeyond empiricism: informing vaccine development through innate immunity researchA vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingHIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.Improvement of cytomegalovirus pp65 DNA vaccine efficacy by co-administration of siRNAs targeting BAK and BAXTherapeutic HPV DNA vaccines.A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cells.A20 controls macrophage to elicit potent cytotoxic CD4(+) T cell response.Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cellsEnhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signalingViral exploitation of host SOCS protein functionsHow can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsSOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag.Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination.Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.Immunological research using RNA interference technology.An effective vaccination approach augments anti-HIV systemic and vaginal immunity in mice with decreased HIV-1 susceptible α4β7high CD4+ T cells.Targeting intracellular signaling: a novel approach to vaccination.HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasionDendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors.Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.Role of SOCS1 in tumor progression and therapeutic application.siRNA and cancer immunotherapy.Engineering better immunotherapies via RNA interferenceMelioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Intratumor RNA interference of cell cycle genes slows down tumor progression.Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.Generating CTLs against the subdominant EBV LMP antigens by transient expression of an A20 inhibitor with EBV LMP proteins in human DCs.Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression
P2860
Q25256562-33687DD3-0B7D-4D96-AD35-BC82A183132EQ26824573-21407DC8-9425-4CD0-AD00-7EE3169A75B6Q28537598-4B85E6B6-E110-4546-A7F9-A0E43CC894F2Q33305012-4FA95AAB-16BB-45FD-8E42-C0B3A1009B93Q33744024-616F385B-2465-43AA-B290-15D991CF5690Q33936427-05F4B40B-BFF7-4F05-B2D0-EC04AD46F613Q34473345-0E7CD3EA-7532-4528-92B3-7DEF846EFAF1Q34473746-173AF85B-5C34-4296-ADC1-D8B419385896Q34519838-8D29A584-8D49-4B7E-A6ED-F2894C94C15AQ34543993-288746AA-6C94-4B1A-9B7C-4B5E53E2F1B9Q34742146-1BB184E3-3C89-4194-9C0A-A3E108B8AC55Q35653703-68AAC31D-8424-4314-974B-BA849AD55E07Q35826747-5D868523-D4E5-48FF-9D5E-C8130011A84FQ36423499-3B1A0969-0AFB-4503-ACF6-A54895B67943Q36600347-BCA56254-7906-4B92-B96C-57D7617D52BEQ36780146-18C031A8-7AC8-40CD-9517-E5BC2EEA161AQ36788606-28AD5751-1C80-40FB-9781-8078C6901C48Q37030417-C090E371-4906-48FD-BC04-A1ED01B75C5AQ37123459-3A264FC8-EB60-4E09-BA89-BACBEF663170Q37253362-189E2943-2C17-4483-95C4-D19794211883Q37309247-A4D21146-1005-4813-A729-198E36082FBFQ37389753-69B303E2-CAC6-4C90-8FD4-D4E9558062BDQ37455362-70C4980B-F7D9-424C-BD29-068FF59AA3ACQ37523971-537B5AE5-F780-459A-BF5F-40DB66029A20Q37949289-BC3FBD42-5BC5-4FE6-BB48-7E59625760E2Q38050504-851277C2-0888-4EE3-A449-5045A5823D27Q38284703-0038529B-FE92-4305-BA1A-650295788ADAQ38890754-9C6C4712-BC61-45E2-9A96-6C135830E419Q39578441-CA1BABB4-1AA8-44CD-9A9E-D0D9C9D50E19Q41580130-A427D7DF-0F83-46A1-BA9B-D85F1C7DD701Q42632595-B1292884-06BD-4F63-838F-659E517FC62CQ57166981-A0DB605E-C486-4112-A489-6AFBECCE4485
P2860
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An alternative and effective H ...... attenuators in dendritic cells
@nl
An alternative and effective H ...... ttenuators in dendritic cells.
@ast
An alternative and effective H ...... ttenuators in dendritic cells.
@en
type
label
An alternative and effective H ...... attenuators in dendritic cells
@nl
An alternative and effective H ...... ttenuators in dendritic cells.
@ast
An alternative and effective H ...... ttenuators in dendritic cells.
@en
prefLabel
An alternative and effective H ...... attenuators in dendritic cells
@nl
An alternative and effective H ...... ttenuators in dendritic cells.
@ast
An alternative and effective H ...... ttenuators in dendritic cells.
@en
P2093
P2860
P1433
P1476
An alternative and effective H ...... ttenuators in dendritic cells.
@en
P2093
Kevin Evel-Kabler
Lisa Rollins
Melissa Aldrich
Si-Yi Chen
Xiao-Tong Song
Xue F Huang
P2860
P356
10.1371/JOURNAL.PMED.0030011
P407
P577
2006-01-03T00:00:00Z